Innovation and regulation in health-tech, Bio-convergence as a use case
Bio-convergence technologies are multi-disciplinary and harbor
complexities, even more so in the biomedical world, where
tight regulation applies and is based on categorization of
products and processes.
The collaboration between the Ministry of Health and the
national Innovation Authority creates a vital framework where
regulatory expertise directly informs funding decisions, enabling
a comprehensive evaluation. This approach helps reduce
investment risks, optimizes resource allocation, and provides companies with coordinated guidance that addresses
compliance requirements and business viability.